Evidence map›Paper›PMID 35326965›Full record

ReviewHealthcare (Basel, Switzerland)2022

Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases.

Sonia Sifuentes-Franco, Dellaneira Carolina Sánchez-Macías, Sandra Carrillo-Ibarra, Juan José Rivera-Valdés, Laura Y Zuñiga, Virginia Aleyda Sánchez-López

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06452134 (Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction in the City of Sanandaj-Iran in 1402), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06452134 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction in the City of Sanandaj-Iran in 1402: a Double-blinded Clinical Trial Study

TypeinterventionalSponsorZahra NejatiRan2024 to 2025Enrolled70ConditionsMolar, Third, Temporomandibular Joint Disorders, Dry Socket, Coenzyme Q10ArmsCoenzyme Q10 100 MG Oral Tablet, Placebo
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Nutraceutical Effects ofNutrients · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sonia Sifuentes-FrancoLaboratory of Biological Systems, Department of Health Sciences, Valles Campus (CUValles), University of Guadalajara (UDG), Ameca 46600, Jalisco, Mexico.ORCID 0000-0003-4647-0350
Dellaneira Carolina Sánchez-MacíasSchool of Health Sciences, Universidad del Valle de México, Zapopan 45010, Jalisco, Mexico.
Sandra Carrillo-IbarraSchool of Health Sciences, Universidad del Valle de México, Zapopan 45010, Jalisco, Mexico.ORCID 0000-0001-8837-5533
Juan José Rivera-ValdésInstitute of Translational Nutrigenetics and Nutrigenomics, Department of Molecular Biology and Genomics, Health Sciences Campus (CUCS), University of Guadalajara (UDG), Guadalajara 44100, Jalisco, Mexico.ORCID 0000-0001-7424-7979
Laura Y ZuñigaDepartment of Health Sciences-Disease as an Individual Process, Tonalá Campus, University of Guadalajara (UDG), Tonalá 45425, Jalisco, Mexico.
Virginia Aleyda Sánchez-LópezPharmacovigilance Department, Laboratorios PISA, Guadalajara 44100, Jalisco, Mexico.
Universidad de Guadalajara · MXUniversidad del Valle de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the appearance of new viruses and infectious diseases (ID) such as COVID-19 in 2019, as well as the lack of specific pharmacological tools for the management of patients with severe complications or comorbidities, it is important to search for adjuvant treatments that help improve the prognosis of infectious disease patients. It is also important that these treatments limit the oxidative and hyperinflammatory damage caused as a response to pathogenic agents, since, in some cases, an inflammatory syndrome may develop that worsens the patient's prognosis. The potential benefits of complementary nutrients and dietary interventions in the treatment of pathological processes in which oxidative stress and inflammation play a fundamental role have been widely evaluated. Coenzyme Q10 (CoQ10) is a supplement that has been shown to protect cells and be effective in cardiovascular diseases and obesity. Additionally, some studies have proposed it as a possible adjuvant treatment in viral infections. Preclinical and clinical studies have shown that CoQ10 has anti-inflammatory and antioxidant effects, and effects on mitochondrial dysfunction, which have been linked to the inflammatory response.

Indexed as

antioxidantCoQ10infectious diseaseinflammation and immunomodulatorubiquinone

Identifiers

PMID35326965
PMCPMC8953254
OpenAlexW4220690102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.